Hip Osteoarthritis study: Lavage chlorhexidine vs Lavage povidone-iodine
Official title Influence of Antiseptic Washes on Wound Healing Complications After THA
ClinicalTrials.gov ID: NCT07104084
What this study is testing
- What it's testing
- The study compares povidone‑iodine and chlorhexidine solutions to find out if one reduces wound healing problems after total hip replacement.
- Who it's for
- Adults undergoing a total hip replacement for hip osteoarthritis or avascular necrosis of the femur head.
- What's involved
- Participants will receive one of the two antiseptic washes during surgery. After surgery, they will have routine follow‑up visits where wound pictures are taken and reviewed.
- Time commitment
- The study lasts until the 6‑week follow‑up visit, with visits at 2 weeks and 6 weeks after surgery.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- osteoarthritis or avascular necrosis of the femoral head, failed conservative management, indicated for total hip replacement
You likely can't join if
- reported or documented allergy to chlorhexidine or povidone-iodine
The study team makes the final eligibility decision.
Where it is enrolling
- Monroeville, Pennsylvania, United States
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Monroeville, Pennsylvania, United States; Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.